![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 9/08 | (2006.01) |
A61P 43/00 | (2018.01) | ||
A61K 38/095 | (2019.01) | ||
A61P 5/10 | (2018.01) | ||
A61K 38/12 | (2006.01) | ||
A61P 1/14 | (2018.01) | ||
A61K 47/12 | (2006.01) | ||
A61K 47/183 | (2013.01) | ||
A61K 47/18 | (2017.01) | ||
A61K 47/12 | (2013.01) | ||
A61K 47/20 | (2006.01) | ||
A61P 25/24 | (2018.01) | ||
A61P 15/04 | (2006.01) | ||
A61K 38/095 | (2019.01) | ||
A61P 25/04 | (2018.01) | ||
A61P 15/04 | (2018.01) | ||
A61P 31/04 | (2018.01) | ||
A61K 38/12 | (2013.01) | ||
A61P 25/00 | (2018.01) | ||
A61P 15/08 | (2018.01) | ||
A61P 19/10 | (2018.01) | ||
A61P 25/22 | (2018.01) | ||
A61P 15/14 | (2018.01) | ||
A61P 15/00 | (2018.01) | ||
A61P 35/00 | (2018.01) | ||
A61P 1/10 | (2018.01) | ||
A61P 7/04 | (2018.01) | ||
A61P 1/00 | (2018.01) | ||
A61P 17/02 | (2018.01) | ||
A61P 25/18 | (2018.01) | ||
A61P 29/00 | (2018.01) | ||
A61P 15/10 | (2018.01) | ||
A61P 7/06 | (2018.01) | ||
A61P 1/04 | (2018.01) | ||
A61K 9/0043 | (2013.01) | ||
A61K 9/0019 | (2013.01) | ||
A61K 47/20 | (2013.01) |
(11) | Patento numeris | 3246018 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 17169301.3 |
Europos patento paraiškos padavimo data | 2011-09-29 | |
(97) | Europos patento paraiškos paskelbimo data | 2017-11-22 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2021-11-03 |
(46) | Apibrėžties vertimo paskelbimo data |
(30) | Numeris | Data | Šalis |
10251690 | 2010-09-30 | EP |
(72) |
NILSSON, Anders , SE
MALM, Mattias , DK
WISNIEWSKI, Kazimierz , US
SIEKMANN, Britta , SE
|
(73) |
Ferring B.V. ,
Polaris Avenue 144, 2132 JX Hoofddorp,
NL
|
(54) | PHARMACEUTICAL COMPOSITION |
PHARMACEUTICAL COMPOSITION |